首頁 > 市場調查報告書 > 醫療設備

生技設備基因治療學和RNAi

市場調查報告書

商品編碼

1532617

微陣列掃描儀市場，按產品類型（螢光、電荷耦合元件、比色微陣列掃描儀）、應用（基因表現、蛋白質微陣列、藥物發現、基因分型和SNP 分析）、最終用途- 全球預測（ 2024 年- 2032 年）

Microarray Scanners Market, By Product Type (Fluorescence, Charge-coupled Devices, Colorimetric Microarray Scanners), Application (Gene Expression, Protein Microarray, Drug Discovery, Genotyping & SNP Analysis), End-use - Global Forecast (2024 - 2032)

出版日期: 2024年05月28日 | 出版商:

Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於微陣列技術在基因組研究、個人化醫療和診斷領域不斷擴大的應用，2024 年至 2032 年間，微陣列掃描器市場規模將達到 8.2% 的複合年成長率。微陣列掃描儀對於分析各個研究領域的基因表現、遺傳變異和生物標記至關重要，包括癌症研究、藥物發現和遺傳性疾病研究。

隨著研究人員和臨床醫生尋求更詳細的遺傳資料見解以客製化治療方法和開發新的治療方法，對能夠提供準確和全面結果的先進微陣列掃描儀的需求正在增加。例如，2023 年 8 月，Thermo Fisher Scientific 推出了一款新的染色體微陣列，用於提高細胞遺傳學研究實驗室的生產力、功效和獲利能力。

更高解析度的成像、更快的掃描速度和更複雜的資料分析工具等改進也使微陣列掃描器更加高效且方便用戶使用。將自動化和軟體解決方案整合到這些掃描器中以減少人工干預並提高吞吐量也將推動市場成長。

整個產業分為產品類型、應用、最終用途和地區。

根據產品類型，電荷耦合元件微陣列掃描儀領域的市場規模將因其高靈敏度和卓越的影像品質而在 2024 年至 2032 年期間獲得顯著成長。電荷耦合元件 (CCD) 技術能夠以優異的解析度精確偵測螢光訊號，這對於準確分析微陣列資料的複雜細節至關重要。基於 CCD 的掃描儀能夠快速捕捉高解析度影像，這也提高了通量和效率，使其對於大規模基因組研究特別有價值。

在應用方面，由於候選藥物高通量篩選和分析技術的快速採用，到 2032 年，藥物發現領域的微陣列掃描儀產業將顯著成長。微陣列掃描儀使研究人員能夠同時評估數千個遺傳和蛋白質靶點，以促進潛在藥物化合物及其對各種生物途徑的影響的識別。

由於強大的研究基礎設施以及對基因組學和個人化醫療的投資不斷增加，預計亞太地區微陣列掃描儀市場將在 2024 年至 2032 年期間產生可觀的收入。慢性病盛行率的上升以及對客製化醫療保健解決方案的日益重視，進一步推動了對高通量技術的需求，促進了區域市場的成長。

產業生態系統分析
產業影響力
- 成長動力
  - 基因組學和蛋白質組學研究的進展
  - 慢性病盛行率上升
  - 科技不斷進步
- 產業陷阱與挑戰
  - 與微陣列掃描器相關的高成本
  - 嚴格的監管要求
成長潛力分析
技術景觀
監管環境
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場估計與預測：按產品類型，2021 - 2032 年

主要趨勢
螢光微陣列掃描儀
電荷耦合元件微陣列掃描儀
比色微陣列掃描儀
其他類型

第 6 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
基因表現分析
蛋白質微陣列
藥物發現
基因分型和 SNP 分析
其他應用

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
醫院和診所
製藥和生物技術公司
診斷實驗室
學術及研究機構
其他最終用戶

第 8 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

Agilent Technologies, Inc.
Arrayit Corporation
Aushon BioSystems
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche Ltd.
Hitachi High-Tech Corporation
Illumina, Inc.
LI-COR Biosciences
Microarrays, Inc.
Oxford Gene Technology
PerkinElmer, Inc.
SciGene Corporation
Tecan Group Ltd.
Thermo Fisher Scientific, Inc.

簡介目錄

Product Code: 9677

Microarray scanners market size will record 8.2% CAGR between 2024 and 2032 driven by the expanding applications of microarray technology in genomic research, personalized medicine, and diagnostics. Microarray scanners are essential for analyzing gene expression, genetic variations, and biomarkers across various research fields, including cancer research, drug discovery, and genetic disorder studies.

With researchers and clinicians seeking more detailed insights into genetic data to tailor treatments and develop new therapeutic approaches, the demand for advanced microarray scanners capable of delivering accurate and comprehensive results is on the rise. For instance, in August 2023, Thermo Fisher Scientific launched a new chromosomal microarray for increasing productivity, efficacy, and profitability in cytogenetic research labs.

Improvements, such as higher resolution imaging, increased scanning speed, and more sophisticated data analysis tools are also making microarray scanners more efficient and user-friendly. The integration of automation and software solutions into these scanners for reducing manual intervention and increasing throughput will also drive the market growth.

The overall industry is classified into product type, application, end-use, and region.

Based on product type, the market size from the charge-coupled devices microarray scanners segment will gain notable traction during 2024-2032 due to their high sensitivity and superior image quality. Charge-coupled device (CCD) technology enables precise detection of fluorescent signals with excellent resolution, which is crucial for accurately analyzing the intricate details of microarray data. The ability of CCD-based scanners to capture high-resolution images at a rapid pace is also enhancing throughput and efficiency, making them particularly valuable for large-scale genomic studies.

In terms of application, the microarray scanners industry from the drug discovery segment will witness significant growth up to 2032 driven by rapid adoption of technologies in high-throughput screening and analysis of drug candidates. Microarray scanners enable researchers to simultaneously evaluate thousands of genetic and protein targets for facilitating the identification of potential drug compounds and their effects on various biological pathways.

Asia Pacific microarray scanners market is expected to generate notable revenue during 2024-2032 attributed to the strong research infrastructure and increasing investments in genomics and personalized medicine. The rising prevalence of chronic diseases and the growing emphasis on tailored healthcare solutions are further propelling the demand for high-throughput technologies, adding to the regional market growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Advancements in genomics and proteomics research
  - 3.2.1.2 Rising prevalence of chronic diseases
  - 3.2.1.3 Growing technological advancements
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost associated with microarray scanners
  - 3.2.2.2 Stringent regulatory requirements
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Fluorescence microarray scanners
5.3 Charge-coupled devices microarray scanners
5.4 Colorimetric microarray scanners
5.5 Other types

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Gene expression analysis
6.3 Protein microarrays
6.4 Drug discovery
6.5 Genotyping and SNP analysis
6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals and clinics
7.3 Pharmaceutical and biotechnology companies
7.4 Diagnostic laboratories
7.5 Academic and research institutes
7.6 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa